Search News

Corporate Industry Technology Medical Updates

Procedure

Medical Updates
A Case Report: Use of Ventricular Assist Device to Enable High-Risk PCI in a Patient with Severe Left Ventricular Dysfunction 2025-09-07
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
Industry
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Medical Updates
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16

Tabs： DonorLife Organ Care System, ISMCS, the first domestically developed extra-VAD, Forbes, the warm blood donor heart transport system, heart failure device, high-risk PCI intraoperative protection, IFAO, lifesaving technology,